Alendronate Sodium Tablet
Product Images NDC 68788-7130

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Alendronate Sodium (NDC 68788-7130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (1203dd0c 809a 4409 B948 B5e816b8a63a 01)

FDA Label Image

2 (1203dd0c 809a 4409 B948 B5e816b8a63a 02)

2 (1203dd0c 809a 4409 B948 B5e816b8a63a 02)
This is a graph displaying the cumulative incidence of hip fractures over a 3-year study of FIT, focused on patients with radiographic vertebral fracture at baseline. On the x-axis there is a timeline displayed in months, and on the y-axis there is a percentage scale ranging from 0% to 12%. There are two lines plotted: one represents the placebo group, and the other represents the alendronate sodium group.*
FDA Label Image

3 (1203dd0c 809a 4409 B948 B5e816b8a63a 03)

FDA Label Image

4 (1203dd0c 809a 4409 B948 B5e816b8a63a 04)

4 (1203dd0c 809a 4409 B948 B5e816b8a63a 04)
Osteoporosis Treatment Studies have been conducted in postmenopausal women, comparing the effect of Alendronate Sodium 10 mg/day versus a placebo. The studies track the time course of the change in Lumbar Spine BMD (bone mineral density) in terms of percentage change from baseline. The data is presented in two sets: a US Study and a Multinational Study. The study duration is represented in months. Unfortunately, the text contains some gibberish characters making it difficult to interpret.*
FDA Label Image

5 (1203dd0c 809a 4409 B948 B5e816b8a63a 05)

FDA Label Image

6 (1203dd0c 809a 4409 B948 B5e816b8a63a 06)

FDA Label Image

7 (1203dd0c 809a 4409 B948 B5e816b8a63a 07)

7 (1203dd0c 809a 4409 B948 B5e816b8a63a 07)
This is a study comparing the effect of Alendronate Sodium 40mg/day vs placebo or Etidronate 400mg/day in patients with Paget's Disease of Bone. The study has a sample size of 27 or 47 individuals and investigates serum alkaline phosphatase levels over time. The results of the study are presented graphically using mean percent change from baseline with standard error bars.*
FDA Label Image

Alendronate Sodium Tablets, Usp 70mg (1203dd0c 809a 4409 B948 B5e816b8a63a 09)

Alendronate Sodium Tablets, Usp 70mg (1203dd0c 809a 4409 B948 B5e816b8a63a 09)
This is a description of Alendronate Sodium tablets, which is the generic drug for Fosamax. Each tablet contains 91 37mg of alendronate sodium thyrate. The recommended dose of the drug should be taken as directed and caution should be taken as it is prohibited by federal law to transfer the drug to any other person than the one it was prescribed to. The manufacturer is Cipla USA. The text also contains product numbers, lot numbers and insurance NDCs.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.